Sánchez Jorge
Grupo de Alergia Clínica y Experimental. IPS Universitaria, Universidad de Antioquía, Medellín, Colombia. Fundación para el Desarrollo de Ciencias Médicas y Biológicas (FUNDEMEB), Cartagena, Colombia. Instituto para Investigaciones Inmunológicas, Universidad de Cartagena, Cartagena, Colombia.
Rev Alerg Mex. 2013 Oct-Dec;60(4):168-71.
Epinephrine is an important life-saving treatment in patients with anaphylaxis.
To evaluate how many patients with a history of anaphylaxis, carry epinephrine with them during medical consultation.
A prospective study was done in the Allergy Unit of the University of Antioquia (Medellin, Colombia), we recruited patients, of all ages, from August 2012 to June 2013, who were referred with suspected anaphylactic reaction for the last 18 months, and were asked about carrying epinephrine with them.
Among 120 patients with a history of anaphylaxis, only 69 (57.5%) had epinephrine in their house or office, and 33 (27.5%) carried it in the medical consultation after 6 months of being prescribed.
Most patients with a history of anaphylaxis do not carry epinephrine with them all the time, and it is necessary to advise the patients, to improve their compliance to treatment.
肾上腺素是过敏反应患者重要的救命治疗药物。
评估有过敏反应病史的患者在就医时随身携带肾上腺素的比例。
在安蒂奥基亚大学过敏科（哥伦比亚麦德林）进行了一项前瞻性研究。我们招募了2012年8月至2013年6月期间所有年龄段的患者，这些患者在过去18个月内被诊断为疑似过敏反应，并询问他们是否随身携带肾上腺素。
在120例有过敏反应病史的患者中，只有69例（57.5%）家中或办公室备有肾上腺素，33例（27.5%）在开处方6个月后就医时随身携带。
大多数有过敏反应病史的患者并非一直随身携带肾上腺素，有必要告知患者，以提高其治疗依从性。
